Clinical Trial Update: A Clinical Trial to Assess the Pharmacokinetics and Safety of AD-229 Compared to AD-2291 in Healthy Adults [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial assessing the pharmacokinetics and safety of AD-229 compared with AD-2291 in healthy adults, sponsored by Addpharma Inc., curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastritis

Drugs mentioned

• AD-229
• AD-2291

Snippet

Sponsor: Addpharma Inc. | Conditions: Gastritis | Phase 1 | Status: NOT_YET_RECRUITING